Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131967) titled 'A multicenter observational study of Nacetylcysteine for severe liver injury related to anti-tumor therapy' on Sept. 8.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: West China Hospital of Sichuan University
Condition:
anti-tumor therapy-related acute liver failure / severe acute liver injury.
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-09-15
Target Sample Size: Observation group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=342358
Disclaimer: Curated by HT Syndication....